- Brain and spinal cord tumors, pediatric cancer segments are contributing notably to growth in the particle therapy market over the forecast period
- North America is witnessing significant increase in cases of brain and spinal cord tumor and that is helping the region account for a notable share of the market
ALBANY, N.Y., Sept. 17, 2020 /PRNewswire/ -- From 2018 to 2026, the compound annual growth rate (CAGR) of global particle therapy market is anticipated to be 8%. It is worth noting here that numerous reasons are seen behind the projected growth, which is set to translate to a higher market worth of USD 727 million by the year 2026 – the end of the aforementioned period. In the year 2017, it is quite pertinent to note, the market valuation stood at USD 364.8 million.
"Incidence of lung cancer in young population, brain and spine tumors in geriatric population is increasing and that is propelling growth in the global particle therapy market over the forecast period", notes TMR
Key Drivers of Growth in Global Particle Therapy Market:
Increasing adoption of pain free treatment is being noted and this is paving way for growth in the market
Number of geriatric people with brain and spine tumors is increasing, propelling the global particle therapy market on an upward curve
Increasing cyclotron service practices noted in countries such as the United States of America is a notable growth factor
Regional Analysis of Global Particle Therapy Market:
Growing geriatric population with brain tumor and spine tumor is being noted in the North American region
These factors are set to drive the aforementioned region on to a dominant position over the forecast period
Contributions of the United States of America towards growth in the region are anticipated to be significant owing to increasing incidence of lung cancer among youth
The country is also witnessing increase in cyclotron services practices and that is propelling growth in the regional therapy market
Notable CAGR will be charted by the Asia Pacific (APAC) region, where Japan and China will be at the forefront of growth
Analyze global particle therapy market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study https://www.transparencymarketresearch.com/sample.php
Competitive Landscape of Global Particle Therapy Market:
The vendor landscape is marked by growth strategies that are shaping the future dynamics of the market. Some of these include proactive measures – organic and inorganic – opted for by leading players. These comprise collaborations and acquisitions, and improvement in geographic reach.
Key players in the global particle therapy market are Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, and Sumitomo Heavy Industries, Ltd., Advanced Oncotherapy PLC., Mevion Medical Systems, Inc., Provision Healthcare, LLC, Optivus Proton Therapy, Inc., Protom International, Inc., and Danfysik A/S. Of these, Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, and Sumitomo Heavy Industries, Ltd. hold a sizeable share of the market. In its report, Transparency Market Research has covered granular information on these players. A part of this information is details into financials, recent developments and growth strategies.
For the study, the Particle Therapy market has been segmented as follows:
Brain and Spinal Cord Tumors (BSCT)
Gastrointestinal (GI) Cancers
Hepatocellular Carcinoma (HCC)
Head and Neck Cancers (HNC)
Ambulatory Surgical Centers
Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:
Autologous Cell Therapy Market: According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is anticipated to expand at a CAGR of 18.1% from 2019 to 2027, rise in prevalence of autoimmune disorders, cancer, blood related disorders, are projected to drive the global market during the forecast period
Compression Therapy Market: According to the report, the global compression therapy market was valued at US$ 3.2 Bn in 2018 and is anticipated to expand at a CAGR of 6.1% from 2019 to 2027, owing to rising sports injuries, increase in the number of orthopedic surgeries, and rapidly growing obese population boost demand for compression therapy products globally
Liposome Drug Delivery Market: Companies in the liposome drug delivery market are increasing their focus on drug delivery nanosystems involving major antiviral classes and their transport across specific barriers at cellular and intracellular levels. Thus, liposomes hold promising potentials in ongoing research studies being carried out by healthcare companies for the treatment of coronavirus
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."